101P - Results of the NLG2105 Phase I Trial Using the IDO Pathway Inhibitor Indoximod, in Combination with Radiation and Chemotherapy, for Children with Newly Diagnosed DIPG
| Autor: | Johnson, T.S., Aguilera, D., Al-Basheer, A., Berrong, Z., Castellino, R.C., Eaton, B.R., Esiashvili, N., Foreman, N., Heger, I.M., Kennedy, E.P., Vahanian, N., Martin, W., Pacholczyk, R., Ring, E., Sadek, R.F., Smith, A., Shimoda, M., Macdonald, T.J., Munn, D.H. |
|---|---|
| Zdroj: | In Annals of Oncology December 2019 30 Supplement 11:xi38-xi38 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|